News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Danaher CEO’s Total Compensation For 2009 Increased 42% From 2008
April 6, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DOW JONES -- Danaher Corp. (DHR) Chief Executive Lawrence Culp's total compensation for 2009 rose 42%, despite a 13% drop in net income last year for the diversified manufacturer because of difficult business conditions.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Layoff Tracker
10x Genomics Slashes 8% of Headcount in Savings Push
May 13, 2025
·
200 min read
·
BioSpace Editorial Staff
Funding
Azafaros Raises $150M To Target Rare Neuro-Metabolic Diseases
May 13, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Lexeo Trims 15% of Workforce, Shifts Focus to Lead Cardiac Programs
May 12, 2025
·
1 min read
·
Angela Gabriel
Manufacturing
Roche makes $300M China Production Promise After Multibillion US Investment
May 12, 2025
·
2 min read
·
Tristan Manalac
